1. Home
  2. PEN vs DAY Comparison

PEN vs DAY Comparison

Compare PEN & DAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • DAY
  • Stock Information
  • Founded
  • PEN 2004
  • DAY 1992
  • Country
  • PEN United States
  • DAY United States
  • Employees
  • PEN N/A
  • DAY N/A
  • Industry
  • PEN Medical/Dental Instruments
  • DAY
  • Sector
  • PEN Health Care
  • DAY
  • Exchange
  • PEN Nasdaq
  • DAY NYSE
  • Market Cap
  • PEN 10.9B
  • DAY 9.1B
  • IPO Year
  • PEN 2015
  • DAY 2018
  • Fundamental
  • Price
  • PEN $266.93
  • DAY $59.06
  • Analyst Decision
  • PEN Strong Buy
  • DAY Buy
  • Analyst Count
  • PEN 16
  • DAY 13
  • Target Price
  • PEN $299.73
  • DAY $73.77
  • AVG Volume (30 Days)
  • PEN 554.0K
  • DAY 2.5M
  • Earning Date
  • PEN 07-29-2025
  • DAY 05-07-2025
  • Dividend Yield
  • PEN N/A
  • DAY N/A
  • EPS Growth
  • PEN N/A
  • DAY N/A
  • EPS
  • PEN 1.08
  • DAY 0.16
  • Revenue
  • PEN $1,240,100,000.00
  • DAY $1,810,300,000.00
  • Revenue This Year
  • PEN $14.60
  • DAY $11.02
  • Revenue Next Year
  • PEN $14.17
  • DAY $11.87
  • P/E Ratio
  • PEN $247.65
  • DAY $364.70
  • Revenue Growth
  • PEN 13.17
  • DAY 14.97
  • 52 Week Low
  • PEN $148.00
  • DAY $47.08
  • 52 Week High
  • PEN $310.00
  • DAY $82.69
  • Technical
  • Relative Strength Index (RSI)
  • PEN 39.77
  • DAY 53.99
  • Support Level
  • PEN $260.38
  • DAY $56.97
  • Resistance Level
  • PEN $275.41
  • DAY $58.74
  • Average True Range (ATR)
  • PEN 9.23
  • DAY 1.35
  • MACD
  • PEN -2.51
  • DAY -0.09
  • Stochastic Oscillator
  • PEN 15.55
  • DAY 73.56

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About DAY DAYFORCE INC

Dayforce provides payroll and human capital management solutions targeting clients with 100-100,000 employees. Following the 2012 acquisition of Dayforce, Dayforce pivoted away from its legacy on-premises Bureau business to become a cloud HCM provider. As of fiscal 2022, about 80% of group revenue was derived from the flagship Dayforce platform geared toward enterprise clients. The remaining revenue is about evenly split between cloud platform Powerpay, targeting small businesses in Canada, and legacy Bureau products.

Share on Social Networks: